Pro-survival effects of repetitive low-grade oxidative stress are inhibited by simultaneous exposure to Resveratrol

Pharmacological Research

Volumn 58, Issue 5-6, 2008, Pages 281-289

  Chakraborty, Prabir Kumar ^a   Mustafi, Soumyajit Banerjee ^a   Raha, Sanghamitra ^a  

^a SAHA INSTITUTE OF NUCLEAR PHYSICS   (India)

Author keywords

Akt; Apoptosis; NF B p65; p38MAPK; Repetitive stress; Resveratrol

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ACETYLCYSTEINE; ANTIOXIDANT; HYDROGEN PEROXIDE; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; RESVERATROL; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR RELA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; LUNG FIBROBLAST; NONHUMAN; OXIDATIVE STRESS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; WESTERN BLOTTING;

ANIMALS; ANTICARCINOGENIC AGENTS; ANTIOXIDANTS; BLOTTING, WESTERN; CELL LINE; CELL SURVIVAL; CRICETINAE; DNA FRAGMENTATION; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FIBROBLASTS; FLOW CYTOMETRY; GENE EXPRESSION; LUNG; MICROSCOPY, CONFOCAL; NF-KAPPA B; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; REACTIVE OXYGEN SPECIES; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STILBENES; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 56649105140     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2008.08.007     Document Type: Article

References (52)

1. Nair V.D., Yuen T., Olanow C.W., and Sealfon S.C. Early single cell bifurcation of pro- and anti-apoptotic states during oxidative stress. J Biol Chem 279 (2004) 27494-27501
2. Martindale J.L., and Holbrook N.J. Cellular response to oxidative stress: signaling for suicide and survival. J Cell Physiol 192 (2002) 1-15
3. 2 in PC12 cells: mechanisms via MMP, ROS and Bcl-2. Brain Res 1057 (2005) 57-64
4. Chen Z.H., Yoshida Y., Saito Y., and Niki E. Adaptation to hydrogen peroxide enhances PC12 cell tolerance against oxidative damage. Neurosci Lett 383 (2005) 256-259
5. 2 exposures protects fibroblasts from subsequent stress-induced apoptosis. Mutat Res 529 (2003) 87-94
6. 2-resistant fibroblasts. Arch Biochem Biophys 292 (1992) 221-227
7. 2-resistant lens epithelial cell line. Free Radic Biol Med 31 (2001) 90-97
8. Mori K., Shibanuma M., and Nose K. Invasive potential induced under long term oxidative stress in mammary epithelial cells. Cancer Res 64 (2004) 7464-7472
9. Coussens L.M., and Werb Z. Inflammation and cancer. Nature 420 (2002) 860-867
10. van der Woude C.J., Kleibeuker J.H., Jansen P.L.M., and Moshage H. Chronic inflammation, apoptosis and (pre) malignant lesions in the gastrointestinal tract. Apoptosis 9 (2004) 123-130
11. Kuehnle K., Crameri A., Kälin R.E., Luciani P., Benvenuti S., Peri A., et al. Prosurvival effect of DHCR24/seladin-1 in acute and chronic responses to oxidative stress. Mol Cell Biol 28 (2008) 539-550
12. Lai C., Peng M., Huang L., Huang W., and Chiu T.H. Chronic exposure of neonatal cardiac myocytes to hydrogen peroxide enhances the expression of catalase. J Mol Cell Cardiol 106 (1996) 157-1163
13. Poswig A., Wenk J., Brenneisen P., Wlaschek M., Hommel C., Quel G., et al. Adaptive antioxidant response of manganese superoxide dismutase following repetitive UVA irradiation. J Invest Dermatol 112 (1999) 13-18
14. 2 treatment through enhancement of mRNA stability. FEBS Lett 579 (2005) 4402-4406
15. Hunt C.R., Sim J.E., Sullivan S.J., Featherstone T., Golden W., Kapp-Herr C.V., et al. Genomic instability and catalase gene amplification induced by chronic exposure to oxidative stress. Cancer Res 58 (1998) 3986-3992
16. Das D.K., and Maulik N. Cardiac genomic response following preconditioning stimulus. Cardiovasc Res 70 (2006) 254-263
17. Halestrap A.P., Clarke S.J., and Khaliulin I. The role of mitochondria in protection of the heart by preconditioning. Biochem Biophys Acta 1767 (2007) 1007-1031
18. Manna S.K., Rangasamy T., Wise K., Sarkar S., Shishodia S., Biswal S., et al. Long term environmental tobacco smoke activates nuclear factor kappa B, activator protein 1, stress responsive kinases in mouse brain. Biochem Pharmacol 71 (2006) 1602-1609
19. Cornejo P., Varela P., Videla L.A., and Fernandez V. Chronic iron overload enhances inducible nitric oxide synthase expression in rat liver. Nitric Oxide 13 (2005) 54-61
20. Liu Y., Shang D., Akatsuka S., Ohara H., Dutta K.K., Mizushima K., et al. Chronic oxidative stress causes amplification and overexpression of ptprz1 protein tyrosine phosphatase to activate β-catenin pathway. Am J Pathol 171 (2007) 1978-1988
21. Sen P., Chakraborty P.K., and Raha S. Tea polyphenol epigallocatechin3-gallate impedes the anti-apoptotic effects of low-grade repetitive stress through inhibition of Akt and NFκB pathways. FEBS Lett. 580 (2006) 278-284
22. Davis C.D. Nutritional interactions: credentialing of molecular targets for cancer prevention. Exp Biol Med 232 (2007) 176-183
23. Pervaiz S. Resveratrol: from grapevines to mammalian biology. FASEB J 17 (2003) 1975-1985
24. Athar M., Back J.H., Tang X., Kim K.H., Kopelovich L., Bickers D.R., et al. Resveratrol: a review of pre-clinical studies for human cancer prevention. Toxicol Appl Pharmacol 224 (2007) 274-283
25. Aggarwal B.B., Bhardwaj A., Aggarwal R.S., Seeram N.P., Shishodia S., and Takada Y. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res 24 (2004) 2783-2840
26. Jang M., Cai L., Udeani G.O., Slowing K.V., Thomas C.F., Beecher C.W.W., et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275 (1997) 218-220
27. Sengottuvelan M., Viswanathan P., and Nalini N. Chemopreventive effect of trans-resveratrol-a phytoalexin against colonic aberrant crypt foci and cell proliferation in 1.2-dimethylhydrazine induced colon carcinogenesis. Carcinogenesis 27 (2006) 1038-1046
28. Bhat K.P.L., Lantvit D., Christov K., Mehta R.G., Moon R.C., and Pezzuto J.M. Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models. Cancer Res 61 (2001) 7456-7463
29. Pervaiz S. Chemotherapeutic potential of the chemopreventive phytoalexin resveratrol. Drug Resist Updates 7 (2004) 333-344
30. Heiss E.H., Schilder Y.D.C., and Dirsch V.M. Chronic treatment with resveratrol induces redox stress- and ataxia telangiectasia-mutated (ATM)-dependent senescence in p53-positive cancer cells. J Biol Chem 282 (2007) 26759-26766
31. Mohan J., Gandhi A.A., Bhavya B.C., Rashmi R., Karunagaran D., Indu R., et al. Caspase-2 triggers bax-bak-dependent and -independent cell death in colon cancer cells treated with resveratrol. J Biol Chem 281 (2006) 17599-17611
32. Chakraborty P.K., Mustafi S.B., Ganguly S., Chatterjee M., and Raha S. Resveratrol induces apoptosis in K562 (chronic myelogenous leukemia) cells by targeting a key survival protein Hsp70. Cancer Sci 99 (2008) 1109-1116
33. Thannickal V.J., and Fanburg B.L. Reactive oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol 279 (2000) 1005-1028
34. Schreck R., Rieber P., and Baeuerle P.A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J 10 (1991) 2247-2258
35. Sen C.K., and Packer L. Antioxidant and redox regulation of gene transcription. FASEB J 10 (1996) 709-720
36. Frantz B., Klatt T., Pang M., Parsons J., Rolando A., Williams H., et al. The activation state of p38 mitogen-activated protein kinase determines the efficiency of ATP competition for Pyridinylimidazole inhibitor binding. Biochemistry 37 (1998) 13846-13853
37. Harikumar K.B., and Aggarwal B.B. Resveratrol: a multitargeted agent for age-associated chronic diseases. Cell Cycle 15 8 (2008) 7
38. Schulz R., Belosjorow S., Gres P., Jansen J., Michel M.C., and Heusch G. p38 MAP kinase is a mediator of ischemic preconditioning in pigs. Cardiovasc Res 55 (2002) 690-700
39. Housenloy D.J., and Yellon D.M. Survival kinases in ischemic preconditioning and postconditioning. Cardiovasc Res 70 (2006) 240-253
40. Han H., Wang H., Long H., Nattel S., and Wang Z. Oxidative preconditioning and apoptosis in L-cells: roles of protein kinase B and mitogen-activated protein kinases. J Biol Chem 276 (2001) 26357-26364
41. Kim D.K., Cho E.S., Lee B.R., and Um H.D. NF-kB mediates the adaptation of human U937 cells to hydrogen peroxide. Free Radic Biol Med 30 (2001) 563-571
42. Keightley J.A., Shang L., and Kinter M. Proteomic analysis of oxidative stress-resistant cells. Mol Cell Proteom 3 2 (2004) 167-175
43. Guo G., Yan-SandersY, Lyn-Cook B.D., Wang T., Tamae D., Ogi J., et al. Manganese superoxide dismutase mediated gene expression in radiation-induced adaptive responses. Mol Cell Biol. 23 (2003) 2362-2378
44. Catz S.D., and Johnson J.L. Transcriptional regulation of bcl-2 by nuclear factor κB and its significance in prostate cancer. Oncogene 20 (2001) 7342-7351
45. Carter A.B., Knudtson K.L., Monick M.M., and Hunninghake G.W. The p38 mitogen-activated protein kinase is required for NF-κB-dependent gene expression: the role of TATA-binding protein (TBP). J Biol Chem 274 (1999) 30858-30863
46. Rane M.J., Coxon P.Y., Powell D.W., Webster R., Klein J.B., Pierce W., et al. p38 kinase-dependent MAPKAPK-2 activation functions as 3-phosphoinositide-dependent kinase-2 for Akt in human neutrophils. J Biol Chem 276 (2001) 3517-3523
47. Madrid L.V., Mayo M.W., Reuther J.Y., and Baldwin A.S. Akt stimulates the transcription potential of the RelA/65 subunit of NFκB through utilization of the IκB kinase and activation of the mitogen-activated protein kinase p38. J Biol Chem 276 (2001) 18934-18940
48. Olson C.M., Hedrick M.N., Izadi H., Bates T.C., Olivera E.R., and Anguita J. p38 mitogen activated protein kinase controls NFκB transcriptional activation and tumor necrosis factor alpha production through Rel A phosphorylation mediated by mitogen and stress activated protein kinase 1 in response to Borrelia burgdorferi antigens. Infect Immun 75 (2007) 270-277
49. Datta S.R., Brunet A., and Greenberg M.E. Cellular survival: a play in three Akts. Genes Dev 13 (1999) 2905-2927
50. Sen P., Mukherjee S., Ray D., and Raha S. Involvement of the Akt signaling pathway with disease processes. Mol Cell Biochem 253 (2003) 241-246
51. Werth C., Stuhlmann D., Steinbrenner H., Alili L., Sies H., and Brenneisen P. Stromal resistance of fibroblasts against oxidative damage: involvement of tumor cell secreted platelet derived growth factor. Carcinogenesis 29 (2008) 404-410
52. Vega M.I., Huerta-Yepaz S., Garban H., Zazirehi A., Emmanouilides C., and Bonavida B. Rituximab inhibits p38MAPK activity in 2F7BNHL and decreases IL-10 transcription: pivotal role of p38MAPK in drug resistance. Oncogene 23 (2004) 3530-3540